Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.75 | N/A |
| PEG Ratio (TTM) | 0.22 | N/A |
| P/S Ratio (TTM) | 1.05 | N/A |
| P/B Ratio (TTM) | 1.25 | N/A |
| P/FCF Ratio (TTM) | 10.85 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.31 | N/A |
| Price to 5YR AVG FCF Ratio | 11.66 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.75% | N/A |
| ROE (TTM) | 17.06% | N/A |
| Net Profit Margin (TTM) | 13.77% | N/A |
| ROIC 5YR AVG | 9.59% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 38.60% | 32.85% | 33.04% |
| Revenue | 0.88% | 1.47% | 1.51% |
| Net Income | 36.88% | 35.33% | 28.14% |
| Cash Flow | 0.62% | 26.63% | 13.38% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 290.03 | N/A |
| Quick Ratio (TTM) | 290.03 | N/A |
| D/E Ratio (TTM) | 0.32 | N/A |
| Interest Coverage (TTM) | 4.12 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.50 | N/A |
| LTL to 5YR AVG FCF | 2.99 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.17% | N/A |